Anne Beall

Policy Analyst


858-200-1805

abeall

You are here

Bio

Anne Beall is working as a policy analyst under the direction of Robert Friedman. Her project focuses on understanding current and future international biotechnology capabilities.

Research Priorities

Anticipating the growth of synthetic biology and genome engineering in the United States, China, and emerging biotechnology nations.

  • Analyze policy and societal drivers that will be influential to each nation’s future progress in the fields of synthetic biology and genome engineering (e.g. societal bioethics, biotechnology regulatory environment, emphasis on bioeconomy).
  • Analyze scientific and technological drivers that will be influential to each nation’s future progress in the fields of synthetic biology and genome engineering (e.g. current biotechnology capabilities, biological data/omics, bioinformatics, support for biotech education and innovation).
  • Identify possible future breakthroughs and their drivers.

Select Publications

Bat Caliciviruses and Human Noroviruses Are Antigenically Similar and Have Overlapping Histo-Blood Group Antigen Binding Profiles.
mBio. 2018-05-22; 9.3:
PMID: 29789360
Allelic Variation in the Toll-Like Receptor Adaptor Protein Ticam2 Contributes to SARS-Coronavirus Pathogenesis in Mice.
G3 (Bethesda, Md.). 2017-06-07; 7.6: 1653-1663.
PMID: 28592648
Efficient Reverse Genetic Systems for Rapid Genetic Manipulation of Emergent and Preemergent Infectious Coronaviruses.
Methods in molecular biology (Clifton, N.J.). 2017-01-01; 1602.59-81.
PMID: 28508214
A mouse model for MERS coronavirus-induced acute respiratory distress syndrome.
Nature microbiology. 2016-11-28; 2.16226.
PMID: 27892925
Characterization of a Pathogenic Full-Length cDNA Clone and Transmission Model for Porcine Epidemic Diarrhea Virus Strain PC22A.
mBio. 2016-01-05; 7.1: e01451-15.
PMID: 26733065